The use of antimicrobials in ten Australian and New Zealand intensive care units

Anaesthesia and Intensive Care

Volumn 26, Issue 6, 1998, Pages 648-653

  Bellomo, R ^a,b,l   Bersten, A D ^a,c   Boots, R J ^a,d   Bristow, P J ^a,e,f   Dobb, G J ^a,g   Finfer, S R ^a,h   McArthur, C J ^a,i   Richards, B ^a,j   Skowronski, G A ^a,k  

^a Australian New Zealand ICMSGI   (New Zealand)

^b AUSTIN HEALTH   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e LIVERPOOL HOSPITAL   (Australia)

^f ALFRED HOSPITAL   (Australia)

^g ROYAL PERTH HOSPITAL   (Australia)

^h ROYAL NORTH SHORE HOSPITAL   (Australia)

ⁱ AUCKLAND CITY HOSPITAL   (New Zealand)

^j GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^k ST GEORGE HOSPITAL   (Australia)

^l Austin and Repatriation Hospital   (United States)

more..

Author keywords

Antibiotics: gentamicin, ceftriaxone, vancomycin, metronidazole; Infection: bacterial, fungal, hospital, intensive care unit, critical illness

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFTRIAXONE; GENTAMICIN; METRONIDAZOLE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUSTRALIA; BACTERIUM CULTURE; CRITICAL ILLNESS; DIARRHEA; DISEASE SEVERITY; DRUG USE; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; RASH; SURGERY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0032441607     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9802600606     Document Type: Article

References (15)

1. Kapusnik-Uner JE, Woods D, Sande M. Antimicrobial therapy in the critical care setting. In: Shoemaker, Ayres, Grenvik, Holbrook, eds. Textbook of Critical Care, W. B. Saunders, Philadelphia 1995; 1236-1249.
2. Harvey K, Stewart R, Hemming M, Moulds R. Use of antibiotics in a large teaching hospital. The impact of antibiotic guidelines. Med J Aust 1983; 2:217-221.
3. Kunin CM. Resistance to antimicrobial drugs: A worldwide calamity. Ann Int Med 1993; 118:557-562.
4. Nichols RL. Surgical antibiotic prophylaxis. Med Clin North Am 1995; 79:509-523.
5. Silver A, Eichorn A, Kral J, et al. Timeliness and use of antibiotic prophylaxis in selected inpatient surgical procedures. The Antibiotic Prophylaxis Study Group. Am J Surg 1996; 171:548-552.
6. Waddell TK, Rotstein OD. Antimicrobial prophylaxis in surgery. Can Med Assoc J 1994; 151:925-931.
7. Di Piro JT, Cheung RPF, Bowden TA Jr, et al. Single dose systemic antibiotic prophylaxis of surgical wound infection. Am J Surg 1986; 152:552-559.
8. Stone HH, Haney BB, Kolb LD, et al. Prophylactic and preventive antibiotic therapy. Timing, duration, and economics. Ann Surg 1979; 189:691-699.
9. Luna C, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685.
10. Vincent J-L, Bihari DJ, Suter P, Bruining HA, White J, Nicolas-Chanoin M-H, Wolff M, Spencer R, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995; 274:639-644.
11. Tibballs J. Teaching hospital medical staff to handwash. Med J Aust 1996; 164:395-398.
12. Yu VL, Korvick JA. Antimicrobial agent therapy for pseudomonas aeruginosa. Antimicrob Agents Chemther 1991; 35:2167-2172.
13. Hatala R, Dinh T, Cook DJ. Meta-analysis: a single dose of aminoglycosides is as effective as multiple daily dosing in immunocompetent adults. Ann Int Med 1996; 124:717-725.
14. Kapusnik JE, Hackbarth CJ, Chambers HF, et al. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. J Infect Dis 1988; 158:7-13.
15. Prins JM, Buller HR, Kuiijper EJ, et al. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341:335-337.